TORONTO--(BUSINESS WIRE)--Kalloghlian Myers LLP is investigating a potential investor class action against DRI Healthcare Trust (the “Trust”) (TSX: DHT.UN) (TSX: DHT.U) and certain current and former trustees and officers.
On July 8, 2024, the Trust announced the resignation of Behzad Khosrowshahi as trustee and CEO as a result of an ongoing investigation of irregularities related to expenses presented by him for reimbursement to the Trust and its manager, DRI Capital Inc.
On this news, the price of the Trust’s Canadian dollar units on the TSX dropped from $15.24 at the close of trading on July 5 to $11.17 at the close of trading on July 8. The Trust’s USD units also declined in price.
Kalloghlian Myers LLP is a Toronto-based law firm specializing in investor class actions.